Prostate Cancer Trial, Recruiting (NCT06856694)

Prostate Cancer Trial, Recruiting NCT06856694 Sponsor: Cedars-Sinai Medical Center Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06856694 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Patients who are attending their first treatment consultation for prostate cancer that has not spread beyond the prostate
Patients who were previously on active surveillance (monitoring without treatment) for prostate cancer but whose cancer has been upgraded and are now considering switching to active treatment
Patients who are able to read and write in English
Doctors who work with prostate cancer patients, including urologists, radiation oncologists, and medical oncologists, may also be invited to participate

Who may not be able to join:

People under 18 years of age
People who have difficulty communicating or who have dementia
People who do not read or write in English, as the tools used in this trial are only available in English
People whose prostate cancer has spread locally beyond the prostate or to other parts of the body
People who have already received treatment for prostate cancer that was confined to the prostate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 310-423-4700

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06856694

Sponsor: Cedars-Sinai Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: 310-423-4700

More information: https://clinicaltrials.gov/study/NCT06856694

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Patients who are attending their first treatment consultation for prostate cancer that has not spread beyond the prostate
Patients who were previously on active surveillance (monitoring without treatment) for prostate cancer but whose cancer has been upgraded and are now considering switching to active treatment
Patients who are able to read and write in English
Doctors who work with prostate cancer patients, including urologists, radiation oncologists, and medical oncologists, may also be invited to participate

Who may not be able to join:

People under 18 years of age
People who have difficulty communicating or who have dementia
People who do not read or write in English, as the tools used in this trial are only available in English
People whose prostate cancer has spread locally beyond the prostate or to other parts of the body
People who have already received treatment for prostate cancer that was confined to the prostate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Cedars-Sinai Medical Center

Registry

ClinicalTrials.gov

Start date

22 October 2025

Est. completion

1 May 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Decisional conflict; Shared decision-making; Appropriateness of treatment choice; Quality of risk communication

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov